Pfizer Inc. (PFE)
Trading Center
Loading...
Symbols:
PFE Forum Topics
- All Comments on PFE
- General Discussion on PFE
- The Long Case for Pfizer [view article]
- Dow Price Targets from Last November [view article]
- The Top Dividend Paying ETFs and Stocks [view article]
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising [view article]
- Biotech Day in Review: Hopeful Results from HIV Conference [view article]
- Looking Inside the New Ben Graham ETN Baskets [view article]
- Time to Invest in Pharmaceuticals? [view article]
- How Have 'Traditional Defensive Stocks' Done in This Downturn? [view article]
- 5 Potential Buyout Targets in Biotech - Barron's [view article]
- Dow 30 Trading Ranges [view article]
- Are Big Pharma's Dollar Days Nearly Over? [view article]
- Young Jeezy's 'The Recession': I Think We’ve Bottomed Out [view article]
loading ...Recent PFE Articles
- The Long Case for Pfizer
- Dow Price Targets from Last November
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
- 2008 Q2 Portfolio Holdings: Berkowitz, Rodriguez & Pabrai
- Looking Inside the New Ben Graham ETN Baskets
- Time to Invest in Pharmaceuticals?
- 5 Potential Buyout Targets in Biotech - Barron's
- Are Big Pharma's Dollar Days Nearly Over?
- China Biotech Week in Review: Earnings and More
- Young Jeezy's 'The Recession': I Think We’ve Bottomed Out
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
The Long Case for Pfizer [view article]
weiwentg said: <<Bruce Berkowitz of Fairholme recently made Pfizer a top holding.>>I think you mean Bristol Myers (BMY). Reply
The Long Case for Pfizer [view article]
The investor who started buying this stock at 21 and "averaged in" every 7% down will end up doing great ReplyDow Price Targets from Last November [view article]
to..user138602...free advertising? What's being advertised? A totally non-thinking comment. Blessed is he who has nothing to say and cannot be persuaded to say it. ReplyDow Price Targets from Last November [view article]
To: ozcutty1...try ignore, not ignor ReplyDow Price Targets from Last November [view article]
To: elGreco...try dramatic, not dramatice ReplyDow Price Targets from Last November [view article]
What a joke analysts really are. I watched Bear Stearns and Countrywide get sold off cheap, yet analysts still had high target prices, ridiculous and a total waste of time.My tip is to live as far away from Wall Street as possible and ignor this mob. Reply
The Long Case for Pfizer [view article]
Every investor should heed "worker on wall street" comments. The one book on investing that sits with me to this day is Burton Malkiel's "A Random Walk Down Wall Street". He thoroughly destroys the notion of the predictability of chartists and makes a compelling case for broad market, long-term holdings.Of course, there's no money in that strategy so he's totally ignored by the CNBC's of the world. Reply
Dow Price Targets from Last November [view article]
If you want to be successful, you have to be able to do it yourself and not rely on so called "experts" like the anal ysts. ReplyDow Price Targets from Last November [view article]
Pretty sobering! ReplyDow Price Targets from Last November [view article]
Similar performance, or lack of, during the 2001 to 2003 period. ReplyDow Price Targets from Last November [view article]
the reason for this poor article , if we can call it like that , is free advertising. Absolutely no subtance,no opinions ,no recommendations, anybody and I really mean ANYBODY can do that with of course a purpose in mind,their own interest not our own (the small investors). ReplyDow Price Targets from Last November [view article]
They are less accurate than a 5 day weather forecast. ReplyThe Long Case for Pfizer [view article]
The comments in posts so far are all well known issues affecting PFE and other big pharma. The question is if PFE has learned a way to overcome them. They have been destroying value for 10 years. They do finally say that they realise they must turn themselves into a biotech company, but I'm not sure. They were always better marketers than scientists. ReplyStreet
The Long Case for Pfizer [view article]
Re: flowcap's comments - as far as "Technical" analysis goes, _any_one can say _any_thing and show charts to "prove" it. I can also show charts to _dis_prove it.We are at a time now where _every_one, from the smartest analysts and money managers, to the elementary school kid doing a portfolio management project, is using this kind of "Technical" analysis. But maybe - just maybe - the tide is turning in favor of fundamental analysis now. And maybe - just maybe - things like business plans, cash flow, cash hoard, product slate, R&D, stability, dividend, international presence.....all of that will matter.
As for the prediction that it will go down and "test the lows again"... who knows - or cares - it may or may not happen. The more important issue is upside vs. downside risk. My approach is to scale in slowly, and keep increasing my position if it continues to go down. Reply
The Long Case for Pfizer [view article]
People will pay ANYTHING for life-saving drugs; but people can lead perfectly happy lives without iPods.That being said, the real concern for Pfizer is that it hasn't invented anything decent for almost a decade, despite burning billions and billions of cash in R&D. Reply